A survival benefit of combination antibiotic therapy for serious infections associated with sepsis and septic shock is contingent only on the risk of death: a meta-analytic/meta-regression study.
about
Beta lactam antibiotic monotherapy versus beta lactam-aminoglycoside antibiotic combination therapy for sepsisIntensive care for cancer patientsAdvances in antibiotic therapy in the critically illRight first time!Antibiotic stewardship in the intensive care unit.Correlations between ACE single nucleotide polymorphisms and prognosis of patients with septic shock.Emerging concepts in optimizing antimicrobial therapy of septic shock: speed is life but a hammer helps tooTherapeutic drug monitoring of amikacin in septic patients.Appraising contemporary strategies to combat multidrug resistant gram-negative bacterial infections--proceedings and data from the Gram-Negative Resistance Summit.Treatment of carbapenem-resistant Klebsiella pneumoniae: the state of the art.Emerging rapid resistance testing methods for clinical microbiology laboratories and their potential impact on patient management.Propensity-based study of aminoglycoside nephrotoxicity in patients with severe sepsis or septic shockTreatment of bloodstream infections in ICUsHow to approach and treat VAP in ICU patients.The Japanese guidelines for the management of sepsis.Beneficial antimicrobial effect of the addition of an aminoglycoside to a β-lactam antibiotic in an E. coli porcine intensive care severe sepsis modelIn vitro activities of 21 antimicrobial agents alone and in combination with aminoglycosides or fluoroquinolones against extended-spectrum-β-lactamase-producing Escherichia coli isolates causing bacteremiaManagement of Adults With Hospital-acquired and Ventilator-associated Pneumonia: 2016 Clinical Practice Guidelines by the Infectious Diseases Society of America and the American Thoracic Society.Empiric antimicrobial therapy in severe sepsis and septic shock: optimizing pathogen clearanceCombination therapy for treatment of infections with gram-negative bacteria.Reducing time to identification of aerobic bacteria and fastidious micro-organisms in positive blood cultures.Impact of inappropriate empiric antimicrobial therapy on mortality of septic patients with bacteremia: a retrospective studyInfluence of multidrug resistance and appropriate empirical therapy on the 30-day mortality rate of Pseudomonas aeruginosa bacteremia.Antibiotic prescription patterns in the empiric therapy of severe sepsis: combination of antimicrobials with different mechanisms of action reduces mortality.Point-of-Care Testing at the Disaster-Emergency-Critical Care Interface.Impact of a high loading dose of amikacin in patients with severe sepsis or septic shock.The clinical impact of multidrug-resistant gram-negative bacilli in the management of septic shock.An alternate pathophysiologic paradigm of sepsis and septic shock: implications for optimizing antimicrobial therapy.From vital signs to clinical outcomes for patients with sepsis: a machine learning basis for a clinical decision support system.Overview of antimicrobial therapy in intensive care units.Rational use of aminoglycosides--review and recommendations by the Swedish Reference Group for Antibiotics (SRGA).Aminoglycosides in septic shock: an overview, with specific consideration given to their nephrotoxic risk.Combination therapy for Gram-negative bacteria: what is the evidence?Antimicrobial stewardship of β-lactams in intensive care units.Combination antibiotic therapy for multidrug-resistant Gram-negative bacteria.Treatment option for sepsis in children in the era of antibiotic resistance.Shortening the course of antibiotic treatment in the intensive care unit.Short-Course Adjunctive Gentamicin as Empirical Therapy in Patients With Severe Sepsis and Septic Shock: A Prospective Observational Cohort Study.A population genomics approach to exploiting the accessory 'resistome' of Escherichia coli.The use and risks of antibiotics in critically ill patients.
P2860
Q24201201-660E448F-C673-48DC-8775-C8DF6AA8F99EQ26749059-4EFD7391-C39F-4145-8C48-91F9CC3F5836Q26749328-F2EE6C63-021D-41C2-9DBD-2E3E2A71B869Q28067972-CE6D413C-0301-489F-8FA3-733CFAA92615Q30408712-68D62DEC-9376-49DE-8AE7-A79C6128DE9AQ33613455-8D823341-9EF0-44D0-AC59-8B82F88E5821Q33752132-2E46422A-E478-4123-A47A-34D665E351F4Q33754166-B320203F-F388-4FEF-96BF-A5198479B3D3Q34003193-0F68CD2B-7314-4AA5-8A0E-B75637F275BDQ34327857-C01093B8-57FF-4951-9386-0275C82004F1Q34342514-F0404F10-4149-4E8C-B705-E1ED18074504Q34597640-226CB0D3-339C-43D1-9633-C2992DD29B9BQ34896896-012D7F05-A423-4385-9653-15CC95E8BA62Q35004845-3279AB95-AE88-4110-B67E-B4C681C4CBB2Q35107094-95341044-E09E-4261-BD5C-C979EABD0A60Q35109053-DBD0031B-D4B8-41A9-AB51-23C613E6CBA8Q35961012-4BC9C865-9DDB-4BCA-8872-0B69C5BA30E5Q36078359-AA257221-1490-49EF-AC48-0D04554D19FFQ36089167-ECF51559-1794-4D5E-ABDE-161DA9172AD1Q36156077-E3B43871-9577-4DA1-9EF4-232447CF4C92Q36161212-750A94FD-C9A9-4865-A25E-C40631AD79C0Q36165152-0D8E57BF-2DA0-4355-85A6-692A3FD9167CQ36172460-DB2855D4-AE75-4820-A841-385A918F76AAQ36902771-2E97F22D-01CF-4186-AB71-761389C32825Q37162163-8FBE9927-B131-46F3-9950-8149E2F1DB92Q37389435-2E761446-43B2-4F2F-9788-6B646C1B8C33Q37563005-8040603A-505F-42EB-8C94-A272CF9DE513Q37563029-8AB385E0-80F2-4725-9D60-66B3B738D6D0Q37598936-30C790EA-105D-43A9-AD5E-FD8D7BEA6EF6Q37822457-BA65E8D0-56D0-49C0-A08E-F23BDDDAE6B8Q38070006-B4704D33-9172-445C-A158-9A7996A5CCB1Q38090988-61701B8E-C8AB-4950-B9D6-5CB5DABBA73EQ38156194-23253A07-22EF-430C-A5B5-1D8698920CDCQ38198157-A1D1735D-ABE4-48E7-A7F2-14E8B3DCB504Q38199180-6FC07C28-BC6E-4929-8ACD-FFE4F39BDC4BQ38246118-30007F59-980F-4F98-A915-0EE3562D6E32Q38341882-1F5A2244-D0DF-4A35-A34D-310A07054FEFQ38432516-731D3C9D-81BC-4E6E-886F-A0C73C57913CQ38635832-2A492575-6A10-4910-AF2B-70971DEF7E91Q38767901-A1C40048-40AC-42C1-A3B7-A86FD7DA19F4
P2860
A survival benefit of combination antibiotic therapy for serious infections associated with sepsis and septic shock is contingent only on the risk of death: a meta-analytic/meta-regression study.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on August 2010
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
A survival benefit of combinat ...... nalytic/meta-regression study.
@en
A survival benefit of combinat ...... nalytic/meta-regression study.
@nl
type
label
A survival benefit of combinat ...... nalytic/meta-regression study.
@en
A survival benefit of combinat ...... nalytic/meta-regression study.
@nl
prefLabel
A survival benefit of combinat ...... nalytic/meta-regression study.
@en
A survival benefit of combinat ...... nalytic/meta-regression study.
@nl
P2093
P1476
A survival benefit of combinat ...... nalytic/meta-regression study.
@en
P2093
Anand Kumar
Dan Chateau
Nasia Safdar
Shravan Kethireddy
P304
P356
10.1097/CCM.0B013E3181E96B91
P407
P577
2010-08-01T00:00:00Z